For citations:
Stepanchenko MV, Zaitsev VG, Gutorov SL. Afatinib: new treatment options for lung cancer with activating EGFR mutations. Meditsinskiy sovet = Medical Council. 2015;(8):50-54. (In Russ.) https://doi.org/10.21518/2079-701X-2015-8-50-54
Stepanchenko MV, Zaitsev VG, Gutorov SL. Afatinib: new treatment options for lung cancer with activating EGFR mutations. Meditsinskiy sovet = Medical Council. 2015;(8):50-54. (In Russ.) https://doi.org/10.21518/2079-701X-2015-8-50-54